Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 is a research paper published in Nature (2021). On theSindex it has a DataRank of 0.806. It has been cited 214 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.806
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: U19 AI135972
NIH HHS
Grant: P30 CA030199-40
NIAID NIH HHS
Grant: U19 AI118610
National Institutes of Health
Grant: 5P30CA030199-37
Cancer Center Support Grant (CCSG)
National Institutes of Health
Grant: 5U19AI135972-04
Fluomics: The Next Generation
National Institutes of Health
Grant: 3U19AI118610-06S3
Administrative Supplement for the HEROS Study Serology
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Genome-wide analysis of protein–protein interactions and involvement of viral proteins in SARS-CoV-2 replication
Additional file 1 of Genome-wide analysis of protein–protein interactions and involvement of viral proteins in SARS-CoV-2 replication
Additional file 1 of Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Additional file 1 of Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Additional file 1 of Modulation of alveolar macrophage and mitochondrial fitness by medicinal plant-derived nanovesicles to mitigate acute lung injury and viral pneumonia
Additional file 1 of Modulation of alveolar macrophage and mitochondrial fitness by medicinal plant-derived nanovesicles to mitigate acute lung injury and viral pneumonia